Hikma Pharmaceutical reported 232M in Selling and Administration Expenses for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
AstraZeneca AZN:LN 2.99B 412M
Bayer BAYN:GR 3.77B 19M
Fresenius FRE:GR 1.3B 100M
Fresenius Medical Care FMS:US 731M 99.18M
Galapagos GLPG:NA 45.45M 15.51M
Genmab GEN:DC 306M 42M
GlaxoSmithKline GSK:LN 2.5B 6M
GRIFOLS GRF:SM 249.86M 7.28M
H. Lundbeck A/S LUN:DC 1.59B 15M
Hikma Pharmaceutical HIK:LN 232M 3M
Merck MRK:GR 1.38B 34M
Orion ORNBV:FH 51.2M 8.9M
Recordati REC:IM 116.24M 1.18M